Correia de Simas Jose Manuel 4
4 · Elanco Animal Health Inc · Filed Mar 3, 2026
Insider Transaction Report
Form 4
Correia de Simas Jose Manuel
SEE REMARKS
Transactions
- Award
Common Stock
2026-03-01+21,507→ 102,907 total - Tax Payment
Common Stock
2026-03-01$26.40/sh−9,883$260,911→ 93,024 total - Award
Common Stock
[F1]2026-03-01+11,364→ 104,388 total - Award
Employee Stock Option (right to buy)
[F2]2026-03-01+23,220→ 23,220 totalExercise: $26.40Exp: 2036-03-01→ Common Stock (23,220 underlying) - Award
Deferred Stock Units (Match)
[F3][F4]2026-03-01+937→ 937 total→ Common Stock (937 underlying)
Footnotes (4)
- [F1]Grant of restricted stock units vesting as follows: one-third vesting on March 1, 2027, one-third vesting on March 1, 2028, and the remaining vesting on March 1, 2029.
- [F2]Grant of stock options vesting as follows: one-third vesting on March 1, 2027, one-third vesting on March 1, 2028, and the remaining vesting on March 1, 2029.
- [F3]Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent.
- [F4]Deferred stock units vest December 31, 2027 and settle upon termination of employment or otherwise in accordance with the Executive Deferral and Stock Match Plan.
Signature
/s/ Amy C. Seidel, as Attorney-in-Fact for Jose Manuel Correia de Simas|2026-03-03